Anticoagulation for patients discharged from the emergency department with venous thromboembolism
While most patients diagnosed with VTE in the ED setting were discharged with DOACs, most cancer patients included in our study were treated with LMWH over DOACs, despite increasing evidence around the efficacy and safety of DOACs in most cancer patients. Further research is needed to understand longitudinal trends in anticoagulation.
Authors
- Karen R. Li (ORCID: https://orcid.org/0000-0002-6672-949X)
- Shelley L. McLeod (ORCID: https://orcid.org/0000-0003-2686-6307)
- Pranav Tandon (ORCID: https://orcid.org/0000-0003-4363-5623)
- Kerstin de Wit
- Keerat Grewal (ORCID: https://orcid.org/0000-0002-2252-1371)
- Cameron Thompson (ORCID: https://orcid.org/0000-0002-3059-7712)
Institutions
- University of Toronto (CA)
- Queens University (BD)
- Schwartz/Reisman Emergency Medicine Institute (CA)
- McMaster University (CA)
Publication Details
- Journal
- The American Journal of Emergency Medicine
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1016/j.ajem.2025.04.009
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00